Division of Bacterial Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
JAMA Netw Open. 2020 Jul 1;3(7):e206004. doi: 10.1001/jamanetworkopen.2020.6004.
Current information on the characteristics of patients who develop sepsis may help in identifying opportunities to improve outcomes. Most recent studies of sepsis epidemiology have focused on changes in incidence or have used administrative data sets that provided limited patient-level data.
To describe sepsis epidemiology in adults.
DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study reviewed the medical records, death certificates, and hospital discharge data of adult patients with sepsis or septic shock who were discharged from the hospital between October 1, 2014, and September 30, 2015. The convenience sample was obtained from hospitals in the Centers for Disease Control and Prevention Emerging Infections Program in 10 states (California, Colorado, Connecticut, Georgia, Maryland, Minnesota, New Mexico, New York, Oregon, and Tennessee). Patients 18 years and older with discharge diagnosis codes for severe sepsis or septic shock were randomly selected. Data were analyzed between May 1, 2018, and January 31, 2019.
The population's demographic characteristics, health care exposures, and sepsis-associated infections and pathogens were described, and risk factors for death within 30 days after sepsis diagnosis were assessed.
Among 1078 adult patients with sepsis (569 men [52.8%]; median age, 64 years [interquartile range, 53-75 years]), 973 patients (90.3%) were classified as having community-onset sepsis (ie, sepsis diagnosed within 3 days of hospital admission). In total, 654 patients (60.7%) had health care exposures before their hospital admission for sepsis; 260 patients (24.1%) had outpatient encounters in the 7 days before admission, and 447 patients (41.5%) received medical treatment, including antimicrobial drugs, chemotherapy, wound care, dialysis, or surgery, in the 30 days before admission. A pathogen associated with sepsis was found in 613 patients (56.9%); the most common pathogens identified were Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Clostridioides difficile. After controlling for other factors, an association was found between underlying comorbidities, such as cirrhosis (odds ratio, 3.59; 95% CI, 2.03-6.32), immunosuppression (odds ratio, 2.52; 95% CI, 1.81-3.52), vascular disease (odds ratio, 1.54; 95% CI, 1.10-2.15), and 30-day mortality.
Most adults experienced sepsis onset outside of the hospital and had recent encounters with the health care system. A sepsis-associated pathogen was identified in more than half of patients. Future efforts to improve sepsis outcomes may benefit from examination of health maintenance practices and recent health care exposures as potential opportunities among high-risk patients.
目前关于发生脓毒症患者特征的信息可能有助于发现改善预后的机会。最近对脓毒症流行病学的研究集中在发病率的变化上,或者使用了提供有限患者水平数据的行政数据集。
描述成人脓毒症的流行病学。
设计、地点和参与者:这项回顾性队列研究对 2014 年 10 月 1 日至 2015 年 9 月 30 日期间从医院出院的脓毒症或脓毒性休克成人患者的病历、死亡证明和医院出院数据进行了回顾。方便样本来自疾病预防控制中心新兴传染病计划的 10 个州(加利福尼亚州、科罗拉多州、康涅狄格州、佐治亚州、马里兰州、明尼苏达州、新墨西哥州、纽约州、俄勒冈州和田纳西州)的医院。随机选择 18 岁及以上出院诊断代码为严重脓毒症或脓毒性休克的患者。数据于 2018 年 5 月 1 日至 2019 年 1 月 31 日进行分析。
描述了人群的人口统计学特征、医疗保健暴露情况以及与脓毒症相关的感染和病原体,并评估了 30 天内脓毒症诊断后死亡的风险因素。
在 1078 名患有脓毒症的成年患者中(569 名男性[52.8%];中位年龄 64 岁[四分位距,53-75 岁]),973 名患者(90.3%)被归类为患有社区获得性脓毒症(即,脓毒症在入院后 3 天内确诊)。共有 654 名患者(60.7%)在入院前有脓毒症相关的医疗暴露史;260 名患者(24.1%)在入院前 7 天有门诊就诊,447 名患者(41.5%)在入院前 30 天内接受了包括抗菌药物、化疗、伤口护理、透析或手术在内的医疗治疗。在 613 名患者(56.9%)中发现了与脓毒症相关的病原体;最常见的病原体是大肠杆菌、金黄色葡萄球菌、肺炎克雷伯菌和艰难梭菌。在控制其他因素后,发现肝硬化(优势比,3.59;95%置信区间,2.03-6.32)、免疫抑制(优势比,2.52;95%置信区间,1.81-3.52)、血管疾病(优势比,1.54;95%置信区间,1.10-2.15)等基础合并症与 30 天死亡率之间存在关联。
大多数成年人的脓毒症发病在医院外,且最近与医疗保健系统有接触。在一半以上的患者中发现了与脓毒症相关的病原体。未来改善脓毒症预后的努力可能会受益于检查维持健康的实践和最近的医疗保健暴露情况,作为高危患者的潜在机会。